Literature DB >> 10613163

Pathologic features in steroid and nonsteroid associated osteonecrosis.

S G Chernetsky1, M A Mont, D M LaPorte, L C Jones, D S Hungerford, E F McCarthy.   

Abstract

Multiple pathophysiologies for osteonecrosis have been postulated and various associated risk factors defined for this disease. However, the pathologic findings of the end stage disease are thought to be similar in all patients. To the author's knowledge, there are no data in the literature comparing the pathologic characteristics of osteonecrosis in a quantitative manner between groups of patients with different associated risk factors. The current study examined the pathologic features of core decompression specimens from the femoral head in a group of patients with osteonecrosis associated with corticosteroid therapy and compared them with specimens from patients with osteonecrosis with no history of corticosteroid therapy. The study group comprised 65 patients (96 hips); 45 patients (68 hips) in the corticosteroid group and 20 patients (28 hips) in the noncorticosteroid group. In the corticosteroid group, 65% of dead bone was identified histologically (44 of 68) as compared with 46% (13 of 28) in the noncorticosteroid group. Specimens staged according to the histologic grading system of Arlet and Durroux revealed the corticosteroid group had a higher incidence of late stage lesions than did the noncorticosteroid group. This was found even though the two groups had similar radiographic staging distribution. The hips in patients who used alcohol were comparable pathologically to the hips in patients who used corticosteroids. This study emphasizes that the histologic features of necrosis and repair are similar in corticosteroid and noncorticosteroid osteonecrosis. However, there were differences in the distribution of viable bone and pathologic stage of the lesions in the two groups, suggesting a more rapid evolution of changes in the corticosteroid group.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10613163

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  14 in total

1.  Effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits.

Authors:  Pengde Kang; Hong Gao; Fuxing Pei; Bin Shen; Jing Yang; Zongke Zhou
Journal:  Int J Exp Pathol       Date:  2010-03-26       Impact factor: 1.925

2.  Effect of blood biochemical factors on nontraumatic necrosis of the femoral head : Logistic regression analysis.

Authors:  Ying Zhang; Ruibo Sun; Leilei Zhang; Lizhi Feng; Youwen Liu
Journal:  Orthopade       Date:  2017-09       Impact factor: 1.087

3.  Accumulation of LDL/ox-LDL in the necrotic region participates in osteonecrosis of the femoral head: a pathological and in vitro study.

Authors:  Xin-Yuan Wang; Tian-Le Ma; Kang-Ning Chen; Zhi-Ying Pang; Hao Wang; Jun-Ming Huang; Guo-Bin Qi; Chen-Zhong Wang; Zeng-Xin Jiang; Lin-Jing Gong; Zhe Wang; Chang Jiang; Zuo-Qin Yan
Journal:  Lipids Health Dis       Date:  2021-11-25       Impact factor: 3.876

Review 4.  Evolutionary course of the femoral head osteonecrosis: Histopathological - radiologic characteristics and clinical staging systems.

Authors:  Yiwei Chen; Yu Miao; Kexin Liu; Feng Xue; Bin Zhu; Changqing Zhang; Guangyi Li
Journal:  J Orthop Translat       Date:  2021-08-16       Impact factor: 4.889

5.  Taxol activates inducible nitric oxide synthase in rat astrocytes: the role of MAP kinases and NF-kappaB.

Authors:  I Cvetkovic; D Miljkovic; O Vuckovic; L Harhaji; Z Nikolic; V Trajkovic; M Mostarica Stojkovic
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

6.  Chicken model of steroid-induced bone marrow adipogenesis using proteome analysis: a preliminary study.

Authors:  Sing Chung Li; Ching Yu Lin; Tzong Fu Kuo; Yun Ho Lin; Chia Chun Chen; Way Neng Lin; Wing P Chan
Journal:  Proteome Sci       Date:  2010-09-14       Impact factor: 2.480

Review 7.  Vasculature deprivation--induced osteonecrosis of the rat femoral head as a model for therapeutic trials.

Authors:  Jacob Bejar; Eli Peled; Jochanan H Boss
Journal:  Theor Biol Med Model       Date:  2005-07-05       Impact factor: 2.432

8.  Levodopa attenuates cellular apoptosis in steroid-associated necrosis of the femoral head.

Authors:  Hongbo Xi; Weijian Tao; Zhengguang Jian; Xuefeng Sun; Xiaohong Gong; Lixin Huang; Tianhua Dong
Journal:  Exp Ther Med       Date:  2016-12-07       Impact factor: 2.447

9.  An epidemiological study of etiology and clinical characteristics in patients with nontraumatic osteonecrosis of the femoral head.

Authors:  Feng Liu; Wei Wang; Lei Yang; Benjie Wang; Jianchuan Wang; Weifang Chai; Dewei Zhao
Journal:  J Res Med Sci       Date:  2017-02-16       Impact factor: 1.852

10.  Short term clinical outcome of a porous tantalum implant for the treatment of advanced osteonecrosis of the femoral head.

Authors:  Mélissa Nadeau; Chantal Séguin; John S Theodoropoulos; Edward J Harvey
Journal:  Mcgill J Med       Date:  2007-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.